Bioprinting: Technologies and Global Markets

Report Highlights

The global market for bioprinting reached $263.8 million in 2015. The market should reach $295 million in 2016 and $1.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 43.9% from 2016 to 2021.

Report Includes

• An overview of the global markets bioprinting.
• Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
• Analysis of the latest techniques used to create cell patterns within a confined space.
• Breakdowns of the market by technology, application, and end-user.
• Evaluation of the market's dynamics, specifically growth drivers, opportunities, and restraints.
• Profiles of major players in the field.

Report Scope

The scope of the report includes bioprinting technologies, applications, industries, markets, patents and companies. The market estimates and forecasts for bioprinting products and services are given for the years 2015, 2016 and 2021.

This report reviews the main bioprinting and bioink platforms, and explains why printing living cells is technically challenging, yet can be extremely rewarding if the technology can be mastered. The report covers the main applications for bioprinting including in vitro models and in vivo regenerative medicine applications.

Industry market driving forces are discussed, including key trends favoring adoption of bioprinting tools.

The report covers the bioprinting markets by workflow, including bioprinting reagents, instruments, software, clinical procedures, and tissue formats such as tissue-on-chip.

The report analyzes the markets for the main bioprinting end-use applications, including research, drug discovery and development, cosmetics, and clinical.

Bioprinting clinical markets discussed include cardiovascular, craniofacial repair, orthopedics, and wound care. The wound care market is analyzed by individual segments, including acute wounds, chronic wounds, and hernia repair.

The specific geographic markets include North America, Europe, Asia/Pacific and the rest of the world.

Market data covers the years 2015, 2016 and 2021.

The report analyzes specific bioprinting-related industries, including 3-D cell culture; bioinks; bioprinting instruments; skin substitutes; and organ/tissue-on-chip.

More than 45 companies in the bioprinting industry are profiled in this report.

BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2014 through mid-2016, including key alliance trends.

Analyst Credentials

John Bergin has produced successful and highly regarded market research reports in the life science industry for BCC research for more than 10 years. Mr. Bergin has held business development and international sales and marketing positions with Corning Inc., an advanced materials company. He has also held executive management positions with IBC Advanced Technologies, a molecular recognition company specializing in separations. Mr. Bergin's extensive expertise in commercializing new technologies is reflected in his market research reports.

Mr. Bergin received a BS degree in Chemistry and Masters of Business Administration (MBA) degree from Brigham Young University and an MS degree in biotechnology from Johns Hopkins University. John Bergin is a pseudonym of the author.

• Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126D)
• Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets (BIO150D)
• DNA Data Storage: Global Markets and Technologies (BIO202A)
• Direct-to-Consumer Genetic Testing: Global Markets and Technologies (MDS008A)
• Next Generation Cancer Diagnostics: Technologies and Global Markets (BIO081C)